发明名称 A MULTIPARTICULATE MODIFIED RELEASE COMPOSITION
摘要 THE INVENTION RELATES TO A MULTIPARTICULATE MODIFIED RELEASE COMPOSITION THAT IN OPERATION DELIVERS AN ACTIVE INGREDIENT IN A PULSED OR BIMODAL MANNER. THE MULTIPARTICULATE MODIFIED RELEASE COMPOSITION COMPRISES AN IMMEDIATE RELEASE COMPONENT AND A MODIFIED RELEASE COMPONENT; THE IMMEDIATE RELEASE COMPONENT COMPRISING A FIRST POPULATION OF ACTIVE INGREDIENT CONTAINING PARTICLES AND THE MODIFIED RELEASE COMPONENT COMPRISING A SECOND POPULATION OF ACTIVE INGREDIENT CONTAINING PARTICLES COATED WITH A CONTROLLED RELEASE COATING; WHEREIN THE COMBINATION OF THE IMMEDIATE RELEASE AND MODIFIED RELEASE COMPONENTS IN OPERATION DELIVER THE ACTIVE INGREDIENT IN A PULSED OR A BIMODAL MANNER. THE INVENTION ALSO RELATES TO A SOLID ORAL DOSAGE FORM CONTAINING SUCH A MULTIPARTICULATE MODIFIED RELEASE COMPOSITION. THE PLASMA PROFILE ACHIEVED BY THE MULTIPARTICULATE MODIFIED RELEASE COMPOSITION IS ADVANTAGEOUS IN REDUCING PATIENT TOLERANCE TO THE ACTIVE INGREDIENT AND IN INCREASING PATIENT COMPLIANCE BY REDUCING DOSAGE FREQUENCY.
申请公布号 MY122159(A) 申请公布日期 2006.03.31
申请号 MYPI9904713 申请日期 1999.11.01
申请人 ELAN PHARMA INTERNATIONAL LIMITED 发明人 DEVANE, JOHN G.;STARK, PAUL;FANNING, NIALL M.M.;GURVINDER SINGH REKHI
分类号 A61K9/14;A61K9/26;A61K9/20;A61K9/40;A61K9/48;A61K9/50;A61K9/54;A61K9/56;A61K9/58;A61K31/4458;A61K47/32;A61P11/00;A61P25/00;A61P43/00 主分类号 A61K9/14
代理机构 代理人
主权项
地址